Colorcon expands functional film coatings through the CR Alliance with DuPont

15 Apr 2019

The Aquacoat product line provides modified release drug profiles with the added benefit of global regulatory acceptance.

DuPont Nutrition & Biosciences, a business unit of DowDuPont Specialty Products Division, has agreed to enhance the current portfolio of Controlled Release (CR) Alliance products distributed by Colorcon by adding the Aquacoat range of modified release products.

Colorcon expands functional film coatings through the CR Alliance with DuPont

The Aquacoat product line includes Aquacoat ECD for sustained release and Aquacoat CPD for enteric coating applications. These aqueous functional coatings are designed for use in both pharmaceutical and nutritional solid dose applications. They provide modified release drug profiles with the added benefit of global regulatory acceptance.

Jayesh Parmar, General Manager at Colorcon says: “The addition of these products further augments the Alliance’s ability to fulfill the needs of the pharmaceutical industry and provide unique solutions to deliver efficiency, cost savings, and dependable performance.”

Martti Hedman, CEO adds: “Colorcon and DuPont, together through the Alliance, continue to deliver increased value and innovative solutions for our pharmaceutical customers. The addition of new products strengthens the global relationship and enhances our market leadership position.”

“We want to ensure that our customers receive the highest possible levels of service,” adds Pauel Fokin, Global Commercial Director, Pharma Solutions, DuPont. “This move provides a one-stop shop for their controlled release application needs and demonstrates our continued commitment to the Controlled Release Alliance with Colorcon.”

Since 2007, the Alliance has served the needs of the pharmaceutical industry, providing customized solutions, products and support services for pharmaceutical product development. The addition of the Aquacoat products into the Alliance portfolio demonstrates the continued strong relationship between Colorcon and DuPont and enhances the range of solutions provided to meet industry needs.

Read More

Related news

Catalent to acquire gene therapy leader Paragon Bioservices

Catalent to acquire gene therapy leader Paragon Bioservices

16 Apr 2019

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare.

Read more 
Catalent celebrates opening of second Shanghai facility

Catalent celebrates opening of second Shanghai facility

15 Apr 2019

Catalent’s two Shanghai locations will provide sponsors with an optimized supply solution for studies being undertaken in China, the Asia-Pacific region and globally.

Read more 
Hovione Technology acquires global rights to new pulmonary inhaler device

Hovione Technology acquires global rights to new pulmonary inhaler device

15 Apr 2019

The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.

Read more 
Exploristics surges ahead with £1m investment

Exploristics surges ahead with £1m investment

14 Apr 2019

The loan will be used to develop KERUS Cloud - currently the only software that can simulate trials with multiple correlated outcomes - by integrating it into an intelligent software ecosystem.

Read more 
Global collaboration to innovate more natural and additive-free nutraceuticals

Global collaboration to innovate more natural and additive-free nutraceuticals

12 Apr 2019

Initiative will enable Sirio Pharma to keep abreast of regional trends, new ingredients, dosage forms and claims to provide customers unique product ideas for line extensions.

Read more 
Isotype-specific secondary antibodies for improved signal detection

Isotype-specific secondary antibodies for improved signal detection

10 Apr 2019

Offers an alternative to cross-adsorbed secondary antibodies when absolute specificity is required.

Read more 
Sterling Pharma to acquire CiVentiChem in the US

Sterling Pharma to acquire CiVentiChem in the US

9 Apr 2019

The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply.

Read more 
New China-based biotechs fueling growth in manufacturing across China

New China-based biotechs fueling growth in manufacturing across China

9 Apr 2019

New guidelines will see poorer quality manufacturers drop out of the market.

Read more 
TTP spin-out to commercialise next-generation cell-sorting technology

TTP spin-out to commercialise next-generation cell-sorting technology

7 Apr 2019

Highway 1 addresses a major unmet need for improved cell-sorting technology, with applications including development of cell therapies, liquid biopsy diagnostics, and high-throughput drug discovery.

Read more 
Catalent expands OptiMelt hot melt extrusion capabilities

Catalent expands OptiMelt hot melt extrusion capabilities

4 Apr 2019

The investment includes the addition of equipment to enhance development capabilities for preclinical and early clinical phase development, as well as adding downstream processing technologies to support HME formulations.

Read more